News from grifols A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

17 Oct, 2019, 10:00 BST Grifols Procleix Panther System With Automation Ready Technology (ART) Receives CE-mark

- ART enables greater workflow efficiency and lean sample management, supporting laboratories' path towards total automation - The Procleix Panther...


03 Jul, 2019, 10:00 BST Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening...


08 Jan, 2019, 12:44 GMT Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions

Grifols, a leading producer of plasma- derived medicines and recognized leader in transfusion medicine, has received U.S. Food and Drug...


27 Oct, 2018, 08:30 BST Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol

Presenting the study results, Antonio Páez, M.D., Grifols Medical Director and Head of the AMBAR Clinical Program confirmed that the analysis of...


12 Oct, 2018, 15:05 BST FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...


23 Jun, 2017, 10:00 BST Grifols adds ID RHD XT diagnostic kit to its molecular portfolio

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the leading companies in the world in plasma-derived biological medicines and transfusion...


12 Jun, 2017, 10:00 BST Grifols announces the launch of Erytra Eflexis, the latest advancement in scalable blood typing solutions that easily adapts to different laboratory workflow needs

- Erytra Eflexis is a fully automated, mid-sized analyzer that performs pretransfusion compatibility testing - This system incorporates two lab...


23 May, 2017, 10:00 BST Grifols Makes Procleix Zika Virus Assay Available for Screening Blood Donations to Countries Accepting CE Mark

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines, now provides European countries...


17 Apr, 2017, 14:00 BST Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program

Today, Grifols, S.A. (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it will donate a minimum of 140 million international units (IU) of blood...


04 Sep, 2016, 10:00 BST Grifols Opens Diagnostic Training Center in Dubai

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with more than 75-year legacy of improving people's health and...


11 Nov, 2013, 07:25 GMT Grifols to acquire a Novartis diagnostics business unit for US$1,675 million

The assets acquired include in vitro diagnostic products and technology for transfusion medicine and immunology, a manufacturing plant in the USA and ...


09 Sep, 2013, 09:00 BST Grifols introduces the AlphaKit® QuickScreen, a novel point-of-care screening device to detect alpha1-antitrypsin (AAT) deficiency, a leading cause of genetic emphysema / COPD in adults

Grifols, a global healthcare company based in Barcelona, Spain, today introduced the AlphaKit® QuickScreen, a novel and efficient point-of-care...


09 Sep, 2013, 09:00 BST Grifols Announces Winners of the 10th Annual eALTA Research Fellowship at 2013 ERS Congress

Grifols, a global healthcare company specializing in the production of biological therapies for rare genetic diseases, today announced the recipients ...


18 Jul, 2013, 13:47 BST Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University

Grifols, a global healthcare company based in Barcelona, Spain with more than 15 years of innovation and expertise with automated drug storage and...


05 Feb, 2013, 17:34 GMT PROLASTIN® celebrates 25 years as leading augmentation therapy for treatment of alpha(1)-antitrypsin deficiency

Grifols, a global healthcare company based in Barcelona, Spain, is commemorating the 25th anniversary year of PROLASTIN® (alpha1-proteinase inhibitor ...


08 Oct, 2012, 17:49 BST Grifols Announces First Patient Enrolled and Dosed in Phase II Trial of Alpha-1 HC Aerosol to Treat Cystic Fibrosis

Grifols, a global healthcare company based in Barcelona, Spain, announced today that the first patient has been enrolled and dosed in a phase II...


04 Sep, 2012, 18:39 BST Grifols Awards Winners of the 9th Annual eALTA Research Fellowship at 2012 ERS Meeting

Grifols, a global healthcare company that specializes in the production of biological medicines derived from human plasma, announced today the...


06 Jun, 2011, 19:15 BST Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations

- Following the recent acquisition of Talecris Biotherapeutics, Grifols has established a new Board of Directors for its US operations that draws on...


07 Mar, 2011, 19:14 GMT Grifols Establishes Expert Advisory Council in Transfusion Medicine

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it has established an Expert...